GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kyverna Therapeutics Inc (NAS:KYTX) » Definitions » Sale Of Investment

Kyverna Therapeutics (Kyverna Therapeutics) Sale Of Investment : $56.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Kyverna Therapeutics Sale Of Investment?

Kyverna Therapeutics's sale of investment for the three months ended in Mar. 2024 was $23.00 Mil. It means Kyverna Therapeutics gained $23.00 Mil from selling investments. Kyverna Therapeutics's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was $56.00 Mil.

Compared with last quarter ($33.00 Mil in Dec. 2023 ), Kyverna Therapeutics gained less money from selling investments in Mar. 2024 ($23.00 Mil).


Kyverna Therapeutics Sale Of Investment Historical Data

The historical data trend for Kyverna Therapeutics's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyverna Therapeutics Sale Of Investment Chart

Kyverna Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Sale Of Investment
- 43.17 46.68

Kyverna Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial 16.60 13.68 - 33.00 23.00

Kyverna Therapeutics Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $56.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kyverna Therapeutics Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Kyverna Therapeutics's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Kyverna Therapeutics (Kyverna Therapeutics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
5980 Horton Street, STE 550, Emeryville, CA, USA, 94608
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR.

Kyverna Therapeutics (Kyverna Therapeutics) Headlines